Categories
- Automotive
- Bearings
- Business Services
- Chemicals and Materials
- Coatings
- Company Profiles
- Consumer Goods
- Defense
- Electronics
- Energy
- Financial Services
- Food & Beverages
- Manufacturing & Construction
- Medical Devices
- Pharmaceuticals and Healthcare
- Public Sector
- Resins
- Technology
- Telecommunications and Wireless
- Vacuum Products
Popular Articles
Sorry. No data so far.
Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design
US$ 2995The complex requirements of manufacturing biological drugs also apply to biosimilars, and these have been a significant barrier to the further expansion of the biosimilars market. A key challenge has been the knowledge gap under which biosimilars are developed, which arises from the fact that innovator product information remains proprietary and biosimilar manufacturers must adopt a reverse engineering process.
04-12 2017 Pages: 117Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies
US$ 2995GBI Research’s latest report, “”Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies””, provides key insights into the global telehealth regulatory and market landscape, as well as its main applications in healthcare and associated sectors.
04-15 2016 Pages: 64The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
US$ 2995GBI Research’s latest report, “”The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects”” discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status.
02-01 2016 Pages: 67Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future
US$ 2995GBI Research’s latest report, “”Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future”” discusses fundamental concepts in biobanking and recent technology advancements in the field.
01-12 2016 Pages: 118Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity
US$ 2995“Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity”” discusses deal-making trends for a range of deal types, such as Mergers & Acquisitions (M&A) and strategic alliances.
12-03 2015 Pages: 77Opioids Overview to 2021 – An Assessment of Pain Management and Dependence
US$ 2995Analysis pertaining to the prescribed opioid users, treatment patterns, and market revenues confirms that the use of weak opioids has fallen dramatically in most markets, while the use of strong opioids has increased. The total market size in the countries covered in this report was $15.7 billion in 2014,
09-20 2015 Pages: 110Life Cycle Management Strategies – Optimizing revenues and defending generic competition
US$ 2995Life Cycle Management Strategies – Optimizing revenues and defending generic competition”” discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies,
08-16 2015 Pages: 100Men’s Health – Changing male attitudes to health to improve prognosis and outcomes
US$ 2995Men’s health refers to conditions that specifically affect males, or those that are not gender-specific but have different outcomes in men. Although still dominated by cardiovascular disease, men’s health is increasingly focusing on other conditions and the wellness of the man overall.
06-12 2015 Pages: 61Women’s Health – Assessing the Need for a Targeted and Specialized Approach
US$ 2995Many of the diseases and conditions that affect mainly women are interlinked with similar root causes; however, placing all of the pieces of the puzzle together to ensure a cohesive management strategy remains a challenge.
06-12 2015 Pages: 69Opioids Market Overview to 2023 – Opioids in Emerging Markets
US$ 2995The report provides analysis of new developments that will have a strong bearing on the use of opioids in pain management in emerging countries (Argentina, Brazil, China, India, Mexico, Russia and South Africa).
06-12 2015 Pages: 72